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Gentamicin activates cultured rat mesangial cells. A role for platelet
activating factor. Gentamicin-induced decreases in glomerular filtration
rate have been associated with a marked decline in the glomerular
capillaiy ultrafiltration coefficient which could be mediated by mesangial
cell contraction or release of vasoactive hormones. We studied the effect
of gentamicin on mesangial cells proliferation, contraction and Ca2
mobilization, Moreover, we attempted to assess a possible role of platelet
activating factor (PAF) as a mediator of the observed effects of gentamicin
on mesangial cells. Gentamicin induced a reduction of planar surface area
of cultured rat mesangial cells that was blunted by the PAF-antagonist,
BN-52021. Gentamicin induced an increase in [Ca2 ] that was inhibited
by BN-52021. Gentamicin also stimulated [3H]thymidine incorporation
into DNA, an effect that was also reduced by BN-52021, and by other two
structurally different PAF receptor antagonists: aiprazolam and BB-823.
Gentamicin induced c-fos mRNA expression in quiescent mesangial cells.
Gentamicin stimulated the synthesis and release of PAF in cultured rat
mesangial cells. The present studies demonstrate that gentamicin activates
mesangial cell function. These actions seem to be mediated, at least in
part, by PAF synthesis and release.
Gentamicin is an aminoglycoside antibiotic which is very effec-
tive in treating difficult gram-negative infections [lj. However, one
of its main side effects is nephrotoxicity, even at lower therapeu-
tical doses [2]. Gentamicin is specifically reabsorbed by proximal
tubular cells [3] and accumulated into the lysosomes, inducing
PIP2-enriched phospholipidosis [2]; it thus causes cellular necro-
sis. However, although gentamicin-induced nephrotoxicity is
mainly tubular and cellular necrosis is confined to cells of the
nephron segment where gentamicin is absorbed [4], chronic
treatment with gentamicin induces decreases in glomerular filtra-
tion rate (GFR) [5]. Schor et a! [5] have shown that the decrease
in GFR induced by gentamicin is due to a marked decline in the
glomerular capillary ultrafiltration coefficient (K1) and in the
glomerular plasma flow rate.
Mesangial cells are perivascular pericytes located within the
central portion of the glomerular tuft between capillary loops [6].
Mesangial cells have a variety of functions including: (a) synthesis
and assembly of the mesangial matrix, which in turn regulates the
viscoelastic and hydraulic properties of the niesangium; (b) endo-
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cytosis and processing of plasma macromolecules including im-
munocomplexes; and (c) control of glomerular hemodynamics via
mesangial cell contraction or release of vasoactive hormones.
Mesangial cell activation could then be responsible for gentamicin-
induced reduction in GFR.
Platelet activating factor (PAF) seems to be one of the several
local mediators which probably plays an important role in the
regulation of Kf [7]. PAF can be synthesized and released by
isolated glomeruli and cultured mesangial cells under various
conditions [8, 9]. When injected into the circulation, PAF induces
a reduction of GFR and RPF [10, 11]. In addition, PAF is able to
contract isolated glomeruli and cultured mesangial cells [12, 13].
We and others [14] have previously demonstrated that PAF plays
a role in gentamicin-induced nephrotoxicity [15].
To evaluate the role of mesangial cells in gentamicin-induced
nephrotoxicity, we studied the effect of gentamicin on mesangial
cell proliferation, contraction, and Ca2 mobilization. Moreover,
we attempted to assess a possible role of PAF as a mediator of the
observed effects of gentamicin on mesangial cells.
Methods
Materials
Collagenase type IA, from Clostridium histolyticum, L-glu-
tamine, sodium selenite, transferrin and insulin (human), phenyl-
methylsulfonyl fluoride (PMSF), PAF (1-O-alkyl-2-acetyl-sn-glyc-
eryl-3-phosphoryl choline) were purchased from Sigma (St. Louis,
MO, USA). Penicillin was obtained from Laboratorios Level SA
(Barcelona, Spain). RPMI 1640, Hank's balanced salt solution,
trypsin-EDTA solution and fetal calf serum were obtained from
Whittaker Laboratories (Barcelona, Spain). BN-52021 was a gift
from Henry Beaufour Institute (Paris, France). Alprazolam was a
gift from Upjohn (Kalamazoo, MI, USA). BB-823 was a gift from
Butsh Biotechnology Limited. Gentamicin was a gift from Anti-
bioticos Farma (Madrid, Spain). [3Hlthymidine and [3Hlacetate
were purchased from New England Nuclear (Bad Homburg,
Germany). Reagents for polymerase chain reactions were ob-
tained from Perkin Elmer Cetus (CT, USA). All the other
reagents were of the highest commercially available grade.
Cell culture
Glomeruli isolated by successive mechanical sieving (150 and
50 tim), from Wistar rats weighing 150 to 200 g, were treated with
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300 U ml1 collagenase, plated in 25 cm2 plastic tissue culture
bottles (Nunc, Denmark) and maintained in the conditions de-
scribed previously [16, 17]. The culture medium consisted of
RPM! 1640 supplemented with 10% FCS, L-glutamine (1 mM),
penicillin (0.66 .tgIml), streptomycin sulfate (60 iWml), and was
buffered with Hepes, pH 7.2. The culture medium was changed
every two days. Studies were performed with cells in the first
passage (21 or 22 days), at which time epithelial cells were no
longer detected in the culture bottles. The identity of the cells was
confirmed by morphological, functional and immunohistochemis-
try criteria described previously [16, 17].
Detennination of planar cell-surface area
Direct observation of mesangial cells grown in conventional
plastic culture plates was carried Out at room temperature under
phase contrast with an inverted Nikon photomicroscope using a
CCD video camera (Hitachi KP 110) and a Hitachi monitor.
Serial photographs of the cells were taken before and after
experimental additions using an on-line videoprinter (Sony UP
910). Five to ten cells were analyzed per photograph. In every
experimental block all the cells were from a single culture.
Experiments were performed in triplicate. Surface area was
determined by computerized image analysis using the IBAS II
image analyzer system (Kontron Medical, Germany). Actual area
was calculated after correction for microscope and photographic
magnification.
Measurement of [Ca2'7,
To measure cytosolic free calcium, ([Ca2]1) cells were raised
from the surface of the culture bottles by treatment with 0.05%
trypsin and 0.02% EDTA. Cell suspensions were incubated for 45
minutes at 37°C in culture medium containing 5 M fura-2 AM.
Then, cells were centrifuged at 1800 rpm for three minutes and
incubated another 15 minutes at 37°C with Hanks solution
without fura-2 to allow time for any non-hydrolyzed fura-2 AM to
diffuse from the cells. Before measurement, the cells were rinsed
again with the Hanks solution containing 1 mi Ca2 and 1 mM
Mg2t Cells were kept in even suspension by continuous stirring.
Fluorescence was measured at 37°C using a fluorescence spectro-
photometer equipped with a thermostatically controlled cuvette
holder (Perkin-Elmer LS5O) at an emission wavelength of 510 nm.
An excitation wavelength of 340 was chosen to monitor the
Ca2tinduced shift in fura-2 fluorescence as determined by pre-
vious calibration determinations. For purposes of calibration in
each experiment, maximal fluorescence was determinated by the
addition of digitonin (50 j.M, final concentration) and minimal
fluorescence by the addition of EGTA (10 m, final concentra-
tion). Autofluorescence was measured in similar cells which had
not been loaded with fura-2 and was below 10% of the total
fluorescence of fura-2 loaded cells in all the experiments. Intra-
cellular calcium concentration was calculated as described by
Olivera and Lopez-Novoa [18],
Proliferation studies
Cell proliferation was measured by both [3H]tjymidine incor-
poration into DNA and measuring viable cell number. For this
purpose, cells were subcultured by treatment with 0.05% trypsin
and 0.02% EDTA, and plated in 6 X 4 well plates (Nunc,
Denmark). Experiments were performed on cells approaching
confluence from the first passage, in order to obviate cell dedif-
ferentiation.
Mesangial cells were made quiescent by removal of their
serum-containing growth media. Washed cells were left in the
same culture medium but with only 0.5% FCS for two days, a time
period at which the cells incorporated a minimum amount of
[methyl-3H]thymidine, indicating a quiescent state. At this point,
the cells were reactivated by exposure to the same culture medium
supplemented with 5 iig/ml insulin, 5 g/ml transferrin, 5 ng/ml
selenium and the agonists or antagonists. Conditions tested
included cells exposed to quiescent medium alone, gentamicin
(10_6 to iO M), BN-52021 at several doses, alprazolam (10 M),
BB-823 (5 >< 10' M) and medium containing 10% FCS as
positive control. After 18 hours of incubation, the cells were
pulsed for six hours with 1 MCi/mt of [methyl3Hjthymidine. The
cell layers were washed with ice-cold phosphate-buffered saline
and fixed with 1 ml of ice-cold 10% trichloroacetic acid for 15
minutes; acid insolubte material was solubilized with 1 ml 0.1 M
NaOH for 30 minutes at 60°C. After NaOH exposure, radioactiv-
ity was measured in a scintillation counter.
We also measured the viable cell number in the wells, using a
commercial modification (Cell Titter 96; Promega, Madison, WI,
USA) of the method of Hansen, Nielson and Berg [19] that has
been previously described [20]. In brief, cells subcultured to
subconfluence in 24 well plates were made quiescent and were
incubated for 24 hours under the experimental conditions de-
scribed above. The medium was removed and 1 ml of fresh
incubation medium was added. Then 150 jil of a solution of
tetrazolium bromide salt [3,(4,5-dimethylthiazol-2-1)2,5-diphenyl-
tetrazolium bromide, 5 mg/mI] were added to each well. The plate
was returned to the incubator for four hours, following which 1 ml
of the solubilization solution containing sodium dodecyl sulphate,
and N,N-dimethyl formamide, pH 4.7, was added. After one hour
at room temperature, the content of the well was mixed thor-
oughly using a Pasteur pipet to obtain a uniform color, and the
content of the wells was transferred to a cuvette and read at 570
nm in a spectrophotometer. Optical density at 570 nm was
proportional to viable cell number in each well [20].
Cell toxicity
To assess whether the concentrations of gentamicin used could
affect mesangial cell viability, cells were plated in 6 x 4 wells
plates, and after reaching subconfluence, medium was removed
and replaced with fresh medium (RPMI 1640 + 10% FCS)
containing gentamicin (10—6 to iO M) or fresh medium alone.
After two hours of incubation, the number of viable cells in each
well was measured by the cell titer method described above.
PAF extraction and incorporation of [3H]acetate into PAF
Specific [3HJacetate incorporation into PAF was measured.
Confluent mesangial cells grown on culture bottles were washed
twice with culture medium without FCS and then incubated with
1 ml of the same medium. Agonist and antagonists were added.
After 30 minutes at 37°C, 75 Ci of carrier-free [3H}acetate and
PMSF (10 M, final concentration) were added, and an addi-
tional 30 minute incubation at 37°C was performed. Reactions
were stopped by the addition of 1 ml of 2% methanol acid, and the
cells were scraped from the surface of the culture bottles. Cell
suspension was centrifuged at 1800 rpm for five minutes, the
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Fig. 1. Effect of the PAF antagonist, BN-52021, on the reduction of
mesangial planar cell surface area (PCSA) induced by gentamicin. Results
are expressed as the percent (%) of the initial PCSA (0%), and each point
represents the mean of at least 3 experiments (5 to 10 cells measured in
each experiment). Symbols are: (0) control cells; (El) iO M gentamicin;(,0 + BN) 5 )< i0 M BN-52021 plus iO— M gentamicin. The curve of
cells treated with gentamicin was statistically different from that of control
cells (*P < 0.01). The curve of cells treated with G+BN was statistically
different from that of control cells (*P < 0.01), and from that of
gentamicin alone ('P < 0.01) (two-way analysis of variance).
supernatant collected, and the precipitate used for protein quan-
titation and then discarded. PAF was extracted from the methan-
olic phase as previously described [21]. In brief, chloroform was
added to the methanol to a proportion of methanol:chloroform
1:1 vol:vol, and gently stirred. After phase formation by centrifu-
gation, the chloroform phase was removed and new chloroform
added to the methanol in the same proportion. The process was
repeated and both chloroform phases were pooled and dried
under N2 atmosphere. Extracts were resuspended in 2 ml chloro-
form acid (2% acetic acid). PAF extraction was performed with
Bond-Elut C18 column (Sep-Pak; Waters, Milford, MA, USA).
These columns were pretreated by successively washing with 2 ml
methanol, 2 ml water and 5 ml of 10% acid acetic in water. Then
the samples were applied to the columns. After this, the columns
were washed twice with 1 ml of 10% acetic acid, followed by three
aliquots of 2 ml ethyl acetate, and finally by 6 ml methanol. The
eluate was collected in polypropylene tubes. The methanol phase
Time, minutes
Fig. 3. Effects of gentamicin and BN-52021 on cytosolic free calcium
(fCa2'7) in cultured rat mesangial cells preloaded with fura-2. Symbols are:(•) control; (A) gentamicin; (LI) gentamicin -I- BN-52021. Data are mean
SEM of2 to 4 experiments. Cells were pretreated with BN-52021 during
15 minutes before adding gentamicin. Cells were treated with iO M
gentamicin and 5 X 10 M BN-52021 plus iO M gentamicin. The curve
of cells treated with gentamicin was statistically different (P < 0.01) from
that of control cells and that of gentamicin plus BN-52021.
was recovered and evaporated to dryness under a gentle stream of
nitrogen. In preliminary studies it was observed that PGE2 and
TXB2 were completely eluted from the cartridge with the two first
solvents, and that nothing of these compounds appeared in the
fractions where PAF was recovered [81. PAF recovery was as-
sessed using [3H]PAF and was found to vary between 70 and 80%.
Extracts were resuspended in 1 ml methanol and the radioactivity
was measured by liquid scintillation spectrometry.
Studies with or without gentamicin were always carried out in
paired experiments using cell culture bottles of the same culture
batch.
c-fos gene &pression
Mesangial cells plated in culture flasks were made quiescent by
removing their serum-containing growth media. Washed cells
were left in the same culture medium without FCS for three days.
Conditions tested included cells exposed to gentamicin (106 to
i0 M) and cells exposed to medium containing 10% FCS as
positive control. After 30 minutes of stimulation, mRNA was
extracted from 5 X iO cells by the NP-40 lysis procedure [22].
The RNA (1 to 2 g) mRNA was submitted to a reverse
transcription reaction using oligo dT primers (Promega) [23]. The
eDNA was amplified by polymerase chain reaction (PCR) using
oligonucleotides derived from two adjacent exons of the actin
gene and the c-fos gene using a thermal cycler and amplitaq DNA
polymerase [24]. Oligonucleotides were synthesized by the De-
partment of Microbiology and Genetics, University of Salamanca,
and their sequences were:
FOS 1:5' CAGCCGACTCTfCTCCAG 3'
FOS2: 5' GCCACGGAGGAGACCAGAGT 3'
AcT1: 5' AGGCCAACCGCGAGAAGATGACC 3'
ACI'2: 5' GAAGTCCAGGGCGACGTAGCAC 3'
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Fig. 2. Effect of gentamicin on intracellular calcium mobilization. The trace
corresponds to a representative experiment from fura-2-loaded mesangial
cells stimulated with iO M gentamicin.
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Fig. 4. Effect of several doses of gentamicin on [3HJthymidine inco7pora-
tion into DNA (A) and on viable cell number (B) in cultured rat mesangial
cells. Each bar represents the mean SEM of at least 5 experiments
performed in triplicate. *Statistically significant differences (P < 0.01)
with respect to cells incubated in control conditions (C) (one-way analysis
of variance).
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Fig. 5. Effect of the PAF antagonist, BN-52021 5 X iO M (BN), on the
increases in [3Hjthymidine incorporation into DNA (A) and on viable cell
number (B) induced by io— M gentamicin (G) in cultured rat mesangial
cells. Each bar represents the mean SEM of at least 4 experiments
performed in triplicate. °Statistically significant differences (P < 0.01)
with respect to cells incubated in control conditions (C); #statistically
significant differences (P < 0.05) with respect to cells incubated with
gentamicin alone (one-way analysis of variance).
Results
Cell contraction
The amplification conditions consisted of denaturation at 94°C
for two minutes, annealing at 60°C for two minutes and extension
at 72°C for two minutes. The number of cycles was 25. PCR
products were size fractioned by agarose gel electrophoresis.
After staining with ethidium bromide, DNA bands were visualized
with an ultraviolet transilluminator.
Statistical methods
In the proliferation studies, each value was obtained as the
mean of three wells. Data are the average of 4 to 12 values.
Percent changes in each experiment were obtained with respect
to its own basal value. Comparisons between means of multiple
groups were analyzed by one-way analysis of variance and
Scheffé's multiple comparisons test. Time course studies were
analyzed by two-way analysis of variance.
Mesangial planar cell surface area (PCSA) decreased signifi-
cantly when cells were incubated with gentamicin (i0 M). This
effect increased progressively as a function of the time (Fig. 1). No
changes could be observed in PCSA of mesangial cells incubated
with culture medium through the whole experimental period.
Considering a 10% of reduction in PCSA as a significant contrac-
tion, gentamicin (10 M) contracted an average of 80% of control
cells after 60 minutes of incubation, whereas less than 10% of
control cells contracted under the same experimental conditions.
Preincubation of mesangial cells with the PAF antagonist,
BN-52021 (5 X 1O M), decreased significantly the contractile
response to gentamicin (Fig. 1). BN-52021 alone did not modify
PCSA.
Cytosolic free calcium changes
Gentamicin (10 M) induced a slow and progressive increase in
[Ca2] from the resting levels (Fig. 2). There was a maintained
*
Rodriguez.Barbero et al: Gentamicin and PAF in mesangial cells 1349
A A
3000
a)
E00
*
3000
2000
1000
0
35000
25000
15000
5000
C 10AM 10-5M 10M
Gentamicin
#
B
C BN G G÷BN
B
1000
0
35000
25000
15000
5000
* a)
0 # #
1350 Rodriguez-Barbero et al: Gentamicin and PAF in mesangial cells
#
ifl
C G G+A G÷BB
__ HrH
C G G÷A G+BB
Fig. 6. Effect of the PAF antagonists, alprazolam 1O M (A) and BB-823
(5 X iO' M) (BB) on [3HJthymidine incolporation into DNA (A) and on
viable cell number (B) induced by iO M gentamicin in cultured rat
mesangial cells. Each bar represents the mean SEM of at least 5
experiments performed in triplicate. *StatiStically significant differences
with respect to cells incubated in control conditions (C) (P < 0.01).
#Statistically significant differences with respect to cells incubated with
gentamicin alone (P < 0.01). Statistically significant differences with
respect to C (P < 0.05) (one-way analysis of variance).
Table 1. Effect of several doses of gentamicin on viable cell number in
cultured rat mesangial cells after two hours of incubation
cells/well
Control (10% FCS)
Gentamicin (10—6 M)
107985 4686
104042 3396
Gentamicin (10 M) 109418 4603
Gentamicin (10—a M) 82087 5086
Data represent the mean SEM of at least 6 experiments performed in
triplicate.aStatistically significant difference (P < 0.01) with respect to cells
incubated in control conditions (one-way analysis of variance).
increase in [Ca2]1, that reached about two times the basal values
at 10 minutes (Fig. 2). When gentamicin (10—i M) was added to
mesangial cells preincubated for 15 minutes with BN-52021 (5 X
iO M), the gentamicin-induced increase in [Ca2J1 was not
observed (Fig. 3).
Cellular proliferation
Gentamicin increased [3Hlthymidine incorporation into DNA
in quiescent mesangial cells, and this increase was significant at
C PAF—9M PAF—8M PAF—BM+BN
Log [PAF]
Log [PAF]
Fig. 7. Effect of BN-52021 (5 X iO M) (RN) on [3H]thymidine incolpo-
ration into DNA (A) and on viable cell number (B) induced by PAF in
cultured rat mesangial cells. Each bar represents the mean SEM of at least
4 experiments performed in triplicate. *Statistically significant differences
with respect to cells incubated in control conditions (C). #Statistically
significant differences with respect to cells incubated with PAF alone (P <
0.05; one-way analysis of variance).
doses of io M and iO M (Fig. 4A). BN-52021 at doses 5 X
iO M significantly reduced the gentamicin (10 M) stimulated
thymidine incorporation into DNA, while no differences with
respect to basal values were observed when mesangial cells were
incubated in the presence of gentamicin (10—i M) and BN-52021
at doses of 5 X i0 M (Fig. 5A). BN-52021 alone had no effect on
thymidine uptake. Two other PAP antagonists, aiprazolam (10—i
M) and BB-823 (5 X 10 M), also significantly reduced the
gentamicin 10 M-stimulated thymidine incorporation into DNA
(Fig. 6A).
Gentamicin increased the number of viable cells in a dose
dependent manner after 24 hours of incubation (Fig. 4B). BN-
52021 significantly reduced the increase in viable cell number
induced by gentamicin (10 M) (Fig. 5B), whereas BN-52021
alone had no effect on cell number. Alprazolam and BB-823 also
significantly reduced the effect of gentamicin on the number of
viable cells (Fig. 6B).
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Fig. 8. Effect of gentamicin (1O M) (G) on [3HJacetate incorporation into
PAF in cultured rat mesangial cells. Each bar represents the mean SEM
of at least 4 experiments perfomed in duplicate. *Statistically significant
differences (P < 0.01) with respect to cells incubated in control conditions
(C) (one-way analysis of variance).
Platelet activating factor stimulated both thymidine incorpora-
tion into DNA and the number of viable cells; these effects were
completely blocked by BN-52021 5 X iO M (Fig. 7).
Cell toxicity
Gentamicin at concentrations of 106 M and iO M did not
modify the number of viable cells in the wells. Gentamicin i0 M
significantly reduced the number of viable cells with respect to
cells incubated in control conditions (Table 1).
PAF synthesis
Figure 8 shows the specific [1H]acetate incorporation into PAF,
in cells incubated or not incubated with gentamicin 10 M (G). In
the presence of gentamicin, [3H]acetate incorporation in to PAF
increased significantly.
Effect of gentamicin on c-fos gene expression
Figure 9 shows a representative agarose gel electrophoresis of
amplification products by RT-PCR of actin and c-fos. Lane M is a
control containing DNA with several molecular weights. A band
of approximately 510 base pairs that corresponds to the calculated
size of the actin gene appears in all the lanes. In cells treated
during 30 minutes with 10% FCS, cDNA amplification gives a
band of approximately 195 base pairs, that corresponds to the
calculated size of c-fos gene (lane 2). Treatment with gentamicin
iO M, 10 M and i0— M for 30 minutes induces the expression
of the c-fos mRNA (lanes 3, 4 and 5). The band corresponding to
c-fos did not appear in quiescent, untreated cells (lane 1) or if
mRNA was extracted after one hour of incubation with gentami-
cm.
The present results demonstrate that gentamicin induced a
reduction of planar cell surface area (PCSA) of cultured rat
mesangial cells. It has been generally accepted that this reduction
in PCSA represents true mesangial cell contraction [6]. Moreover,
a reduction in Kf [251 has been shown with several vasoactive
substances that cause reduction in PCSA, and also glomerular
contraction [13]. In addition, previous studies have shown that
reduction in PCSA was associated with an increase in myosin light
chain phosphorylation [26].
Associated with the reduction in PCSA, gentamicin also in-
duced a slow but sustained increase in [Ca2] in mesangial cells.
The relationship between mesangial cell contraction and in-
creased [Ca2]1 has been reported for several vasoactive sub-
stances [6]. Incubation with gentamicin also stimulated mesangial
cell proliferation, demonstrated by both the increase in cell
number and the increase in DNA synthesis. The lower prolifera-
tive effect of the higher concentrations of gentamicin can be
explained by the relative toxicity of this dose, as demonstrated in
the studies of cell viability after two hours of incubation. Cell
proliferation is also an event associated with increased [Ca2] in
mesangial cells [27]. Gentamicin induced c-fos mRNA expression
in mesangial cells. c-fos and c-jun mRNA expression has been
associated to cell proliferation in mesangial cells [27]. c-fos and
c-jun proteins are the structural components of AP-1 complex, an
important transacting factor that binds to cis elements in pro-
moter and enhancer regions of numerous genes and regulates
their expression [281.
At least a substantial part of the mesangial cell activation by
gentamicin seems to be mediated by the activation of synthesis
and release of PAF by mesangial cells. In addition, gentamicin
enhances the incorporation of acetate into PAF in cultured
mesangial cells. This is deduced from the fact that gentamicin-
induced mesangial cell contraction was partially abolished by
preincubation with the PAF antagonist BN-52021 [29]. This
blockade seems to be specific, since it has been previously shown
that BN-52021 blocked PAF-induced but not angiotensin-induced
mesangial cell contraction [17]. Further support to the role for
PAF in mesangial cell activation is given by the facts that the
gentamicin-induced increase in [Ca2]1 and mesangial cell prolif-
eration were also blocked by preincubating the cells with several,
nonstructurally selected PAF antagonists, such as BN-52021,
alprazolam [29] and BB-823 [30]. It has already been demon-
strated that PAF can be released by mesangial cells [9] and
isolated rat glomeruli [8]. PAF induces mesangial cell contraction
[12] and also proliferation, as shown in this study and in previous
studies [20, 31]. We have previously demonstrated that the
contractile effects of cyclosporin A [16], endothelin [321 and
reactive oxygen species [261 on cultured rat mesangial cells are
mediated by synthesis and release of PAF.
Thus, PAF synthesis and release could represent a common
pathway of mesangial cell activation by different heterogeneous
stimuli. Furthermore, a role for PAF in the renal effects of
gentamicin is also supported by the data of Pavao dos Santos et al
[14] and RodrIguez-Barbero et al [15], demonstrating that the
administration of PAF antagonists partially protected against the
reduction in renal function induced by gentamicin treatment.
In conclusion, the present studies demonstrate that gentamicin
induces mesangial cell contraction and proliferation, c-fos mRNA
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Fig. 9. Effects of gentamicin on c-fos mRNA
expression in cultured rat mesangial cells. In cells
treated during 30 minutes with 10% FCS,
cDNA amplification gives a band of
approximately 195 base pairs, which correspond
with the calculated size of the c-fos gene (lane
2). Treatment with iO M (lane 3), iO M
(lane 4), and 106 M (lane 5) gentamicin
induces the expression of the c-fos mRNA.
expression and increase in [Ca2]. These actions seem to be
mediated, at least in part, by PAF synthesis and release. The effect
of gentamicin on mesangial cells could play a role in gentamicin-
induced decrease in renal function.
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